Literature DB >> 17651845

Exercise training in advanced heart failure patients: discordance between improved exercise tolerance and unchanged NT-proBNP levels.

Michael Arad1, Yehuda Adler, Nira Koren-Morag, Shy Natanzon, Ben-Ami Sela, Issahar Ben Dov, Michael Shechter, Ehud Schwammenthal, Dov Freimark.   

Abstract

BACKGROUND: Exercise training can improve aerobic capacity and symptoms in congestive heart failure (CHF) patients. AIMS: To test the feasibility of exercise training in advanced CHF patients, and examine the potential benefit from peripheral vascular and muscular conditioning as well as improved central hemodynamic and neurohumoral status. METHODS AND
RESULTS: Thirty NYHA functional class III, CHF patients (mean age 61+/-13 yr, ejection fraction 27+/-4%, VO2max 11.3+/-3.9 ml/kg/min) were enrolled. Exercise capacity, cardiovascular parameters and serum levels of brain natriuretic peptide (NT-proBNP) were determined at baseline and after 18 weeks of moderate intensity exercise training. Twenty eight (93%) patients, who completed the exercise program, experienced marked improvements in the 6 min walk (+39%) and exercise duration on the modified Bruce protocol (+66%). Smaller improvements were recorded in the cardiac index (a 15% increase), in the maximal oxygen consumption (a 13% increase in VO2max), in the left ventricular ejection fraction (an 11% increase) and in the systemic vascular resistance and pulmonary artery pressure (an 11% decrease). NT-proBNP levels were not significantly affected. They correlated with exercise capacity and VO2max on baseline measurement, but these correlations were not found after training.
CONCLUSION: Rehabilitation is feasible, even in advanced CHF, and leads to markedly improved exercise performance, but does not affect the level of the principal neurohumoral marker of prognosis - NT-proBNP. Resting cardiovascular performance and maximal oxygen consumption improve less than functional capacity, suggesting that an important benefit is derived from muscle conditioning and improved peripheral vascular response to exercise.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651845     DOI: 10.1016/j.ijcard.2007.05.005

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION).

Authors:  W Schuyler Jones; Robert Clare; Stephen J Ellis; James S Mills; David L Fischman; William E Kraus; David J Whellan; Christopher M O'Connor; Manesh R Patel
Journal:  Am J Cardiol       Date:  2011-05-10       Impact factor: 2.778

Review 2.  The Effects of an Oral Taurine Dose and Supplementation Period on Endurance Exercise Performance in Humans: A Meta-Analysis.

Authors:  Mark Waldron; Stephen David Patterson; Jamie Tallent; Owen Jeffries
Journal:  Sports Med       Date:  2018-05       Impact factor: 11.136

Review 3.  Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review.

Authors:  Eisuke Amiya; Masanobu Taya
Journal:  Clin Med Insights Cardiol       Date:  2018-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.